Human defined antigenic region on the nucleoprotein of Crimean-Congo hemorrhagic fever virus identified using truncated proteins and a bioinformatics approach

被引:26
|
作者
Burt, F. J. [1 ,2 ]
Samudzi, R. R. [1 ]
Randall, C. [1 ]
Pieters, D. [1 ]
Vermeulen, J. [1 ]
Knox, C. M. [3 ]
机构
[1] Univ Orange Free State, Fac Hlth Sci, Dept Med Microbiol & Virol, ZA-9300 Bloemfontein, South Africa
[2] Universitas, Natl Hlth Lab Serv, ZA-9300 Bloemfontein, South Africa
[3] Rhodes Univ, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, South Africa
关键词
Crimean-Congo hemorrhagic fever virus; Antigenicity; Nucleoprotein; PEPTIDES; EXPRESSION; EPITOPES;
D O I
10.1016/j.jviromet.2013.07.055
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne viral zoonosis widely distributed in Africa, Asia and eastern Europe. In this study, amino acid sequence data for the CCHFV nucleoprotein (NP) was used to identify potential linear epitopic regions which were subsequently included in the design of large and small truncated recombinant NP antigens and peptide libraries. Two truncated recombinant CCHFV NP antigens were prepared based on results of prediction studies to include epitopic regions and exclude hydrophobic regions that could influence protein expression and solubility. Serum samples were collected from acute and convalescent patients. An IgG antibody response was detected in 16/16 samples tested using the large recombinant NP-based ELISA and in 2/16 using the small recombinant NP-based ELISA. A total of 60 peptides covering predicted epitopic regions of the NP were synthesized and peptide NRGGDENPRGPVSR at amino acid position 182-195, reacted with 13/16 human serum samples. In summary, functional assays are required to determine the biological activity of predicted epitopes for development of peptide based assays for antibody detection. Bacterially expressed complete NP antigens have previously been shown to be useful tools for antibody detection. Truncation of the antigen to remove the hydrophobic C terminus had no impact on the ability of the antigen to detect IgG antibody in human sera. The results indicate that the region from amino acids 123 to 396 includes a highly antigenic region of the NP with application in development of antibody detection assays. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:706 / 712
页数:7
相关论文
共 50 条
  • [1] Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein
    Lombe, Boniface Pongombo
    Saito, Takeshi
    Miyamoto, Hiroko
    Mori-Kajihara, Akina
    Kajihara, Masahiro
    Saijo, Masayuki
    Masumu, Justin
    Hattori, Takanari
    Igarashi, Manabu
    Takada, Ayato
    VIRUSES-BASEL, 2022, 14 (03):
  • [2] Evolution of Crimean-Congo Hemorrhagic Fever virus
    Anagnostou, Vassiliki
    Papa, Anna
    INFECTION GENETICS AND EVOLUTION, 2009, 9 (05) : 948 - 954
  • [3] A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus
    Hirano, Minato
    Sakurai, Yasuteru
    Urata, Shuzo
    Kurosaki, Yohei
    Yasuda, Jiro
    Yoshii, Kentaro
    ANTIVIRAL RESEARCH, 2022, 200
  • [4] Fine Epitope Mapping of the Central Immunodominant Region of Nucleoprotein from Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
    Liu, Dongliang
    Li, Yang
    Zhao, Jing
    Deng, Fei
    Duan, Xiaomei
    Kou, Chun
    Wu, Ting
    Li, Yijie
    Wang, Yongxing
    Ma, Ji
    Yang, Jianhua
    Hu, Zhihong
    Zhang, Fuchun
    Zhang, Yujiang
    Sun, Surong
    PLOS ONE, 2014, 9 (11):
  • [5] Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein
    Tipih, Thomas
    Heise, Mark
    Burt, Felicity Jane
    VACCINES, 2021, 9 (12)
  • [6] Recombinant nucleoprotein-based serological diagnosis of Crimean-Congo hemorrhagic fever virus infections
    Saijo, M
    Tang, Q
    Shimayi, B
    Han, L
    Zhang, YZ
    Asiguma, M
    Tianshu, D
    Maeda, A
    Kurane, I
    Morikawa, S
    JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (02) : 295 - 299
  • [7] A Crimean-Congo Hemorrhagic Fever Case in an Endemic Region in November
    Tavsan, Oznur
    Duygu, Fazilet
    Kaya, Turan
    KLIMIK JOURNAL, 2012, 25 (03) : 130 - 132
  • [8] Crimean-Congo Hemorrhagic Fever Virus: Advances in Vaccine Development
    Tipih, Thomas
    Burt, Felicity Jane
    BIORESEARCH OPEN ACCESS, 2020, 9 (01): : 137 - 150
  • [9] Molecular biology and pathogenesis of Crimean-Congo hemorrhagic fever virus
    Kraus, Annette A.
    Mirazimi, Ali
    FUTURE VIROLOGY, 2010, 5 (04) : 469 - 479
  • [10] The impact of Crimean-Congo hemorrhagic fever virus on public health
    Mertens, Marc
    Schmidt, Katja
    Ozkul, Aykut
    Groschup, Martin H.
    ANTIVIRAL RESEARCH, 2013, 98 (02) : 248 - 260